Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

We have used a nonmyeloablative conditioning regimen consisting of total-body irradiation (2 Gy) with or without fludarabine (30 mg/m(2)/d for 3 days) for related and unrelated hematopoietic cell transplantation (HCT) in patients with hematologic malignancies who were not candidates for conventional...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 23; no. 9; pp. 1993 - 2003
Main Authors:	BARON, Frédéric, MARIS, Michael B, MALONEY, David G, STORB, Rainer, SANDMAIER, Brenda M, STORER, Barry E, SORROR, Mohamed, DIACONESCU, Razvan, WOOLFREY, Ann E, CHAUNCEY, Thomas R, FLOWERS, Mary E. D, MIELCAREK, Marco
Format:	Journal Article Web Resource
Language:	English
Published:	Baltimore, MD American Society of Clinical Oncology 20-03-2005 Lippincott Williams & Wilkins Amer Soc Clinical Oncology
Subjects:	Adolescent Adult Aged Biological and medical sciences Child Child, Preschool Comorbidity Female Graft Rejection Graft vs Tumor Effect - drug effects Graft vs Tumor Effect - radiation effects Hematology Hematopoietic Stem Cell Transplantation - methods Human health sciences Humans Hématologie Immunosuppressive Agents - therapeutic use Leukemia - mortality Leukemia - therapy Male Medical sciences Middle Aged Oncologie Oncology Probability Sciences de la santé humaine Transplantation Conditioning - methods Treatment Outcome Tumors Vidarabine - analogs & derivatives Vidarabine - therapeutic use Cancerology Graft versus tumor reaction Stem cell Hematopoietic cell Homograft Graft Non myeloablative treatment
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!